1-1 of 1
Ken Sasaki
Close
Sort by
Journal Articles

CAMK2G is identified as a novel therapeutic target for myelofibrosis

Masashi Miyauchi, Ken Sasaki, Yuki Kagoya, Kazuki Taoka, Yosuke Masamoto, Sho Yamazaki, Shunya Arai, Hideaki Mizuno, Mineo Kurokawa
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1585–1597.
https://doi.org/10.1182/bloodadvances.2020003303
Published: 2022
Includes: Supplemental data